Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer
Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer
M. Beck,D. Böhmer,15 Authors,T. W. G. O. T. H. Society
2019 · DOI: 10.1007/s00066-019-01553-3
15 Citations
TLDR
Dose-escalated RT alone appears to be an appropriate treatment in favorable intermediate-risk patients, and addition of short course ADT (4–6 months) might improve outcomes in unfavorable intermediate- risk patients.